SeriousConflict
Losartan blocks angiotensin II type 1 receptors, reducing aldosterone secretion and thereby decreasing renal potassium excretion. Adding potassium supplementation on top of this potassium-retaining effect can cause hyperkalemia, a potentially life-threatening condition that can lead to cardiac arrhythmias, heart block, and cardiac arrest. The risk is highest in patients with renal impairment, diabetes, or those taking other potassium-sparing agents.
Recommendation: Avoid potassium supplementation while taking losartan unless directed by your prescriber with regular lab monitoring. Do not use potassium-containing salt substitutes. Have serum potassium checked within 1-2 weeks of starting losartan and periodically thereafter. Seek immediate medical attention for muscle weakness, palpitations, or numbness.
ModerateConflict
Losartan is a prodrug metabolized by CYP2C9 and CYP3A4 to its active metabolite E-3174, which is 10-40 times more potent than the parent compound. St. John's Wort induces CYP3A4 and potentially CYP2C9, which could accelerate losartan metabolism. However, because St. John's Wort induces the activating enzymes, it could paradoxically either increase or decrease the active metabolite, making the net clinical effect unpredictable and warranting caution.
Recommendation: Avoid combining St. John's Wort with losartan. The unpredictable effect on losartan's activation pathway makes monitoring difficult. If blood pressure control deteriorates, consider St. John's Wort as a possible cause. Allow 10-14 days for enzyme induction effects to develop or resolve.
SeriousCaution
Losartan blocks the AT1 receptor and reduces sodium reabsorption, which causes the kidney to retain lithium. A published case described a previously stable prescription-lithium patient developing tremor, confusion, and elevated lithium levels within weeks of starting losartan 50 mg. Lithium Orotate doses are smaller but use the same renal pathway and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking losartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.
ModerateCaution
A systematic review of antihypertensive therapy and zinc identified increased urinary zinc loss in losartan-treated patients. The effect is smaller than with sulfhydryl-containing ACE inhibitors but is consistent across studies of ARB therapy. Symptoms of zinc deficiency include altered taste, slow wound healing, hair loss, and reduced immune function.
Recommendation: If you take losartan long term, a modest zinc supplement (15-30 mg/day) or a multivitamin containing zinc is reasonable, especially if you notice altered taste or recurrent infections. Take zinc with food to limit GI upset.
InfoSynergy
Garlic Extract lowers blood pressure modestly (approximately 4-10 mm Hg systolic in hypertensives). When combined with the ARB losartan, the effects are additive, which can help patients with uncontrolled hypertension but may produce mild hypotension if blood pressure is already at goal.
Recommendation: If your blood pressure is already well controlled on losartan, monitor at home before and after starting Garlic Extract. Typical aged garlic doses are 600-1200 mg/day. Tell your prescriber so your losartan dose can be adjusted if needed.
InfoSynergy
Magnesium supplementation lowers blood pressure modestly (about 2-3 mm Hg systolic and 2 mm Hg diastolic) when added to antihypertensive medication. Combined with losartan the effect is additive and generally beneficial, though it may produce mild hypotension if blood pressure is already at goal.
Recommendation: Magnesium Citrate 200-350 mg elemental magnesium daily is a reasonable add-on; monitor home blood pressure after starting. Tell your prescriber so your losartan dose can be reviewed. Reduce dose if you develop loose stools.
InfoSynergy
Vitamin D directly suppresses renin biosynthesis, so vitamin D deficiency leaves the renin-angiotensin system over-activated. Correcting deficiency in losartan-treated patients may modestly improve blood pressure control and reduces upstream RAAS activation that ARBs are trying to counter. The combination is well tolerated.
Recommendation: If your 25-hydroxyvitamin D level is below 30 ng/mL, supplementing 1000-2000 IU/day of Vitamin D3 is reasonable, with periodic level checks. Monitor home blood pressure after starting and tell your prescriber.
InfoSynergy
Fish Oil reduces blood pressure modestly and has independent renoprotective effects through reduced angiotensin II generation and downregulation of TGF-beta. Combined with losartan the effects are additive and well tolerated, with potential benefit in proteinuria.
Recommendation: Fish Oil 1-3 g/day of combined EPA+DHA is a reasonable add-on; monitor home blood pressure after starting and tell your prescriber. Higher doses (greater than 3 g/day) may modestly raise bleeding risk.
ModerateCaution
Berberine can inhibit CYP2C9 activity and may alter losartan conversion to its active metabolite E-3174. Berberine may also lower blood pressure, so the combination could change blood pressure response or increase lightheadedness in sensitive users.
Recommendation: If you use berberine with losartan, start berberine cautiously and monitor home blood pressure during the first 1 to 2 weeks. Report dizziness, fainting, unusual fatigue, or loss of blood pressure control to your prescriber.
ModerateCaution
Berberine HCl can inhibit CYP2C9 activity and may alter losartan conversion to its active metabolite E-3174. Berberine HCl may also lower blood pressure, so the combination could change blood pressure response or increase lightheadedness in sensitive users.
Recommendation: If you use berberine HCl with losartan, start berberine HCl cautiously and monitor home blood pressure during the first 1 to 2 weeks. Report dizziness, fainting, unusual fatigue, or loss of blood pressure control to your prescriber.
NutriStack